BRIEF—New Nuvo Pharmaceuticals CEO

Toronto-listed Nuvo Pharmaceuticals has appointed Jesse Ledger, previously the president of the company, as president and chief executive officer.

Former CEO John London will become executive chairman and will continue to serve on the board of directors.

"My goal is to make Nuvo a growth oriented pharmaceutical company through the expansion and diversification of our proprietary-product portfolio and the continued global expansion of our Pennsaid 2% business," said Mr Ledger.